InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Robertson Michelle, Chief Financial Officer. Director active across 3 companies, notably Editas Medicine, Inc.. Aggregated, 16 reports have been recorded. Split: 0 buy · 8 sells. Total volume traded: €133k. Activity tracked since 28 June 2021. The latest transaction was disclosed on 18 February 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Robertson Michelle
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
27,500 shares0Common StockSEC:0001755098-26-000001:0
8,333 shares0Common StockSEC:0001104659-25-053103:0
8,333 shares0Common StockSEC:0001104659-24-073608:0
949 shares@ US$9.8722.0% of flowCommon StockSEC:0001415889-23-007990:0
31,500 shares0Common StockSEC:0001415889-23-004315:0
4,287 shares@ US$9.66539.0% of flowCommon StockSEC:0001415889-23-002603:0
1,752 shares@ US$8.16013.1% of flowCommon StockSEC:0001415889-23-000875:0
193 shares@ US$10.230.4% of flowCommon StockSEC:0001415889-22-012132:0
192 shares@ US$15.010.7% of flowCommon StockSEC:0001415889-22-009449:0
1,527 shares@ US$11.53696.2% of flowCommon StockSEC:0001415889-22-006161:0
767 shares@ US$17.32774.5% of flowCommon StockSEC:0001415889-22-002655:0
53,499 shares0Common StockSEC:0001415889-22-001223:0
1,744 shares@ US$25.7015.0% of flowCommon StockSEC:0001179110-22-000470:0
4,471 shares0Common StockSEC:0001179110-21-011224:0
2,500 shares@ US$30.6524.8% of flowCommon StockSEC:0001179110-21-008086:0
2,500 shares@ US$30.6524.4% of flowCommon StockSEC:0001179110-21-007175:0
16 of 16 declarations
About Robertson Michelle
Michelle Robertson is Chief Financial Officer and appears in 16 filings. Across the 16 sampled filings between 2021-06-30 and 2026-02-19, sale amounts total EUR 133399 and the most frequent transaction nature is Sale, with filings tied to Editas Medicine, Inc. and Geron Corp. and Verastem, Inc.
